Pharmaceutical packaging is much more than putting tablets, capsules or injections into a container. It is an important part of manufacturing because the package must protect the medicine from moisture, oxygen, light, contamination and physical damage.

For pharmaceutical companies, packaging also supports product stability, identification, transportation and safe use. FDA requirements specifically state that drug-product container closure systems must provide adequate protection against external factors that could cause deterioration or contamination.

According to Towards Healthcare Research ann Consulting, the global pharmaceutical manufacturing industry size was estimated at USD 616.19 billion in 2025 and is predicted to increase from USD 652.67 billion in 2026 to approximately USD 1095.2 billion by 2035, expanding at a CAGR of 5.92% from 2026 to 2035

Role of Packaging in Pharma Manufacturing

Packaging starts with selecting materials that are compatible with the drug formulation. The packaging must not negatively affect the medicine through interaction, contamination or loss of product quality.

For sterile products, container-closure integrity becomes particularly important because a defective closure can compromise sterility. FDA guidance also highlights the need to evaluate container-closure integrity and the suitability of packaging components.

Packaging also supports traceability through labels, batch numbers, expiry dates, serialization and other product-identification information.

Major Types of Pharmaceutical Packaging

Primary packaging directly contacts the medicine. Examples include glass vials, ampoules, plastic bottles, prefilled syringes, blister packs, strips and sachets.

Secondary packaging provides additional protection and information. Cartons, labels, leaflets and some protective components fall into this category.

Tertiary packaging is mainly used for transportation and distribution, including shipping boxes, pallets and protective materials.

Blister packaging commonly combines a forming film with a lidding material, while bottles may use materials such as HDPE with screw or snap closures.

Demand and Industry Opportunity

Demand for pharmaceutical packaging is closely connected to pharmaceutical manufacturing volumes, biologics, injectables, generic medicines and specialty drugs.

India is particularly important because its pharmaceutical industry includes around 3,000 drug companies and approximately 10,500 manufacturing units. India is also the world's largest supplier of generic medicines by volume, supplying about 20% of the world's generic medicine supply.

India's broader packaging industry was valued at approximately US$84 billion in 2024 and is projected to reach about US$143 billion by 2029, according to IBEF.

Key Challenges

The biggest challenges include maintaining container-closure integrity, controlling extractables and leachables, preventing contamination, ensuring material compatibility and meeting increasingly complex regulatory requirements.

Sustainability is another growing concern. Pharmaceutical companies need packaging that provides strong protection while reducing material use and improving recyclability.

Regulatory expectations are also evolving. In 2026, FDA issued draft guidance specifically addressing the evaluation of container closure systems for drugs and biological products.

Jobs and Career Opportunities

Pharmaceutical packaging creates employment across production, quality, engineering, validation, regulatory affairs and supply-chain functions.

Current job listings demonstrate demand for specialized roles; LinkedIn recently showed 98 pharmaceutical-packaging-related jobs in India, including packing and packaging positions at companies such as Sun Pharma and Intas Pharmaceuticals.

Common roles include Packaging Engineer, Packaging Development Executive, Production Executive, QA/QC Specialist, Validation Engineer, Packaging Material Scientist and Regulatory Affairs Specialist.

As pharmaceutical manufacturing becomes more sophisticated, packaging is increasingly treated as a critical part of product quality rather than simply the final manufacturing step.